Mirae Asset Global Investments’s CorMedix CRMD Stock Holding History

Mirae Asset Global Investments’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.9K	Buy	4,110 +281	+7%	+$2.08K	﹤0.01%	1387
2025 Q4	$44.5K	Buy	3,829 +943	+33%	+$10.4K	﹤0.01%	1419
2025 Q3	$33.6K	Buy	2,886 +266	+10%	+$3.22K	﹤0.01%	1412
2025 Q2	$32.3K	Buy	2,620 +610	+30%	+$6.73K	﹤0.01%	1321
2025 Q1	$13.5K	Sell	2,010 -12	-0.6%	-$124	﹤0.01%	1436
2024 Q4	$16.6K	Buy	+2,022	New	+$20.2K	﹤0.01%	1447
2024 Q1	–	Sell	-23,751	Closed	-$89.3K	–	2475
2023 Q4	$89.3K	Hold	23,751	–	–	﹤0.01%	2484
2023 Q3	$87.9K	Hold	23,751	–	–	﹤0.01%	2490
2023 Q2	$94.2K	Buy	+23,751	New	+$118K	﹤0.01%	2529

Other funds holding CRMD

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Mirae Asset Global Investments's CRMD Position: Q1 2026 in Review

Mirae Asset Global Investments increased its CorMedix (CRMD) stake by 7.3% in Q1 2026, buying an estimated $2.08K and bringing the position to 4,110 shares worth $27.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1387.

Mirae Asset Global Investments first reported a position in CRMD in Q2 2023 and has held it in 9 quarters since. The position peaked at $94.2K in Q2 2023. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

Mirae Asset Global Investments held 4,110 shares of CorMedix worth $27.9K as of Q1 2026.
Mirae Asset Global Investments bought 281 CorMedix shares in Q1 2026, an estimated $2.08K.
CorMedix made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q1 2026, its #1387 holding.
Mirae Asset Global Investments first reported a position in CorMedix in Q2 2023 and has held it in 9 quarters since.
Mirae Asset Global Investments's CorMedix position peaked at $94.2K in Q2 2023.
187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Mirae Asset Global Investments's 13F filing for Q1 2026, filed 4 May 2026.